Mometasone-based triple combination therapy in melasma: Is it really safe?

Indian Journal of Dermatology

Volumn 55, Issue 4, 2010, Pages 359-362

  Majid, Imran ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Melasma; mometasone; triple combination treatment

Indexed keywords

GLYCOLIC ACID; HYDROQUINONE; MOMETASONE FUROATE; STEROID;

ACNE; ADOLESCENT; ADULT; ARTICLE; CHLOASMA; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; HYPERTRICHOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; QUESTIONNAIRE; RETROSPECTIVE STUDY; SKIN ATROPHY; SKIN SENSITIVITY; TELANGIECTASIA; TREATMENT DURATION;

EID: 78651331442     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.74545     Document Type: Article

References (13)

1. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: A clinical, light microscopic, ultrastructural and immunofluorescence study. J AM Acad Dermatol 1981;4:698-710.
2. Grimes PE. Melasma, Etiologic and therapeutic considerations. Arch Dermatol 1995;131:1453-7.
3. Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994;130:727-33.
4. Amer M, Metwalli M. Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol 1998;37: 449-50.
5. Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa D Jr. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 2003;42:153-6.
6. Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis 2003;72:67-72.
7. Neering H. Treatment of melasma (chloasma) by local application of a steroid cream. Dermatologica 1975;151: 349-53.
8. Kanwar AJ, Dhar S, Kaur S. Treatment of melasma with potent topical corticosteroids. Dermatology 1994;188:170.
9. Arndt KA, Bowers KE. Manual of dermatologic therapeutics. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002.
10. Goa KL. Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs 1988;36: 51-61.
11. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975;111:40-8.
12. Torok HM. A comprehensive review of the long-term and shortterm treatment of melasma with a triple combination cream. Am J Clin Dermatol 2006;7:223-30.
13. Torok H, Taylor S, Baumann L, Jones T, Wieder J, Lowe N, et al. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. J Drugs Dermatol 2005;4:592-7.